# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-022451
Filing Date
2024-04-26
Accepted
2024-04-26 16:12:07
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ny20022201x3_ars.pdf | ARS | 1258323
| Complete submission text file | 0001140361-24-022451.txt |  | 1734333

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-24006 | Film No.: 24883857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)